WuXi AppTec controversies
Controversies tied to this brand in public sources. A listing is not a finding of fault.
Back to profile3 entries
2026
Section 1260H Chinese military-company designation
The U.S. Department of Defense included WuXi AppTec on its Section 1260H list. WuXi described the designation as incorrect and unsupported, and filed a federal lawsuit seeking to overturn it.
2026
WuXi AppTec discloses cybersecurity incident affecting DEL platform
Issue disclosure
WuXi AppTec announced on the evening of August 24 that its DNA-encoded library (DEL) platform under its biology business segment had recently suffered a cybersecurity incident. The company activated emergency response procedures, engaged external cybersecurity experts and legal counsel, and said its IT systems were operating normally and the DEL platform's security was under control, with no evidence found that data had been publicly disclosed, misused or improperly exploited. The company contacted affected biology business segment clients and said operations and service capability were unaffected.
Company response
Investigation — 药明康德
事件发生后，公司第一时间启动应急处置机制，聘请专业外部网络安全专家与法律顾问，全面开展事件核查与应对工作。
Ongoing disclosure — 药明康德
公司已主动联系受本次网络安全事件影响的生物学业务板块客户，开展充分的客户沟通解释工作。
Source excerpt
公司已主动联系受本次网络安全事件影响的生物学业务板块客户，开展充分的客户沟通解释工作。
8月24日晚，药明康德发布公告称其生物学业务板块DNA编码化合物库（DEL）平台近期遭遇一起网络安全事件。
事件发生后，公司第一时间启动应急处置机制，聘请专业外部网络安全专家与法律顾问，全面开展事件核查与应对工作。
2024
U.S. national-security and intellectual-property allegations
WuXi AppTec faced allegations in U.S. political and media discussions that it had relationships with Chinese state or military institutions and that U.S. client intellectual property or data may have been transferred to Chinese authorities without consent. WuXi denied unauthorized transfers, denied affiliation with the Chinese Communist Party or People's Liberation Army, and said it complies with U.S. law.